Wednesday, 3 April 2019

Transplanted bone marrow endothelial progenitor cells delay ALS disease progression

Transplantation of human bone marrow-derived endothelial progenitor cells (EPCs) into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier (BSCB), University of South Florida researchers report.

* This article was originally published here